ADC Therapeutics SA (ADCT)
4.04
-0.15
(-3.58%)
USD |
NYSE |
May 14, 16:00
3.99
-0.05
(-1.24%)
Pre-Market: 20:00
ADC Therapeutics Profit Margin (Quarterly): -258.2% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -258.2% |
| December 31, 2023 | -510.4% |
| September 30, 2023 | -329.9% |
| June 30, 2023 | -244.3% |
| March 31, 2023 | -312.6% |
| December 31, 2022 | -36.51% |
| September 30, 2022 | -66.31% |
| June 30, 2022 | -372.3% |
| March 31, 2022 | -35.83% |
| December 31, 2021 | -202.1% |
| Date | Value |
|---|---|
| September 30, 2021 | -544.2% |
| June 30, 2021 | -1.93K% |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | -1.19K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.93K%
Minimum
Jun 2021
-35.83%
Maximum
Mar 2022
-464.1%
Average
-312.6%
Median
Mar 2023
Profit Margin (Quarterly) Benchmarks
| Roche Holding AG | -- |
| Novartis AG | 22.18% |
| AC Immune SA | -- |
| CRISPR Therapeutics AG | -- |
| Addex Therapeutics Ltd | -1.86K% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -53.98% |
| Return on Invested Capital | -591.8% |
| Gross Profit Margin (Quarterly) | 86.10% |
| Operating Margin (Quarterly) | -184.8% |
| Return on Net Operating Assets | -345.2% |